Merz Aesthetics Announces FDA Approval Of Xeomin (incobotulinumtoxinA) For The Temporary Improvement In The Appearance Of Moderate To Severe Glabellar Lines In Adult Patients

Links shared publicly online about this topic.

  • 129
    total visits

Merz Aesthetics Announces FDA Approval Of Xeomin (incobotulinumtoxinA) For The Temporary Improvement In The Appearance Of Moderate To Severe Glabellar Lines In Adult Patients

drugs.com

Xeomin (incobotulinumtoxinA) is used to treat Glabellar Lines. Includes Xeomin side effects, interactions and indications.

View full resource at drugs.com

Tags: FDA, Xeomin

  • Share

Most Recently Shared on July 22, 2011 at 2:14 am By:

drugscom Drugs.com

Merz Aesthetics Announces FDA Approval of Xeomin (incobotulinumtoxinA) for Glabellar Lines - http://bit.ly/ndckiH

9 months ago...

FDA approves Merz Aesthetics' XEOMIN for temporary improvement of glabellar lines

news-medical.net — “Merz Aesthetics today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved XEOMIN for the temporary improvement in the appearance of moderate to severe glabellar lines, or frown lines between the eyebrows, in adult patients.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on July 22, 2011 at 2:17 pm By:

Pregnancy_News News-Medical.Net Health News

Pregnancy News: FDA approves Merz Aesthetics' XEOMIN for temporary improvement of glabellar lines: Merz Aestheti... http://bit.ly/ncYv2I

9 months ago...

Xeomin Approved for Improvement of Frown Lines - ONA

oncologynurseadvisor.com — “Merz Aesthetics announced that Xeomin has been approved for the (incobotulinumtoxinA) for the temporary improvement in the appearance of moderate to severe glabellar lines, or frown lines between the eyebrows, in adult patients.View full resource at oncologynurseadvisor.com

  • View Related
  • Share

Most Recently Shared on July 21, 2011 at 4:44 pm By:

Xeomin Approved for Improvement of Frown Lines - MPR

empr.com — “Merz Aesthetics announced that Xeomin has been approved for the (incobotulinumtoxinA) for the temporary improvement in the appearance of moderate to severe glabellar lines, or frown lines between the eyebrows, in adult patients.View full resource at empr.com

  • View Related
  • Share

Most Recently Shared on July 21, 2011 at 4:15 pm By:

eMPR MPR Medical Publisher

MPR News: Xeomin Approved for Improvement of Frown Lines: Merz Aesthetics announced that Xeomin has been approve... http://bit.ly/rq3FRM

9 months ago...

Advertisement